Arcutis Biotherapeutics Files for $100 Million IPO

Arcutis Biotherapeutics Files for $100 Million IPO

Source: 
CP Wire
snippet: 

On 1/6/2020, Arcutis Biotherapeutics filed the paperwork for their $100 Million IPO. The Westlake Village, CA based company is focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. The company intends to trade on NASDAQ under the symbol, “ARQT."